Bausch Health
BHC
$8.62
Share price
0.70%
Change (1 day)
21.07%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Revenue for Bausch Health (BHC)
Revenue in 2023 (TTM): $8.22 B
According to Bausch Health 's latest financial reports the company's current revenue (TTM) is $8.22 B. In 2022 the company made a revenue of $8.12 B a decrease over the years 2021 revenue that were of $8.43 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Bausch Health from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $8.22 B | 1.25% |
| 2022 | $8.12 B | -3.68% |
| 2021 | $8.43 B | 5.07% |
| 2020 | $8.02 B | -6.67% |
| 2019 | $8.60 B | 2.64% |
| 2018 | $8.38 B | -3.94% |
| 2017 | $8.72 B | -9.82% |
| 2016 | $9.67 B | -7.21% |
| 2015 | $10.42 B | 26.17% |
| 2014 | $8.26 B | 43.23% |
| 2013 | $5.76 B | 62.68% |
| 2012 | $3.54 B | 43.97% |
| 2011 | $2.46 B | 108.55% |
| 2010 | $1.18 B | 43.98% |
| 2009 | $0.82 B | 8.35% |
| 2008 | $0.75 B | -10.16% |
| 2007 | $0.84 B | -20.62% |
| 2006 | $1.06 B | 13.35% |
| 2005 | $0.93 B | 5.91% |
| 2004 | $0.88 B | 7.37% |
| 2003 | $0.82 B | 4.53% |
| 2002 | $0.78 B | 35.11% |
| 2001 | $0.58 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | -89.50% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | -100.00% | 🇺🇸 USA |